CORVAC
Live / Registered — Registered (as of 07 Jun 2022)
What this means for you
Registered since 07 Jun 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79296041
- Registration number
- 6749038
- Mark type
- Stylized text
- Filed
- 18 Aug 2020
- Published for opposition
- 15 Feb 2022
- Registered
- 07 Jun 2022
- Attorney of record
- CATHERINE C MILLER
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, in particular for the prevention and treatment of cancer, infectious diseases, autoimmune diseases and other immunological diseases, in particular by means of nucleic acids, self-replicating nucleic acids, viruses, virus-like particles, peptides and proteins; nucleic acids coding for receptor proteins for the stimulation and proliferation of cells of the immune system for medical purposes; all the foregoing for human use
- Class 042 — Scientific and technological services: Medical and scientific research, in particular in the field of the prevention and treatment of immunological diseases, the treatment of cancer, the prevention of cancer and the treatment and prevention of infectious diseases; scientific research services relating to pharmaceutical information, the rendering of scientific research advice in the field of the prevention and treatment of immunological diseases, the treatment of cancer, the prevention of cancer and the treatment and prevention of infectious diseases; all the foregoing for human use
- Class 044 — Medical, beauty and agricultural services: Medical services, in particular providing therapeutic methods and vaccination methods for the treatment and prevention of cancer, infectious diseases and immunological diseases; medical and pharmaceutical advisory services; medical diagnostic testing, monitoring and reporting services; medical services relating to information in the nature of providing medical information, the rendering of medical advice in the field of the prevention and the treatment of immunological diseases, the treatment of cancer, the prevention of cancer and the treatment and prevention of infectious diseases; all the foregoing for human use
Owner
- BioNTech SE, DE
- BioNTech SE, DE
- BioNTech SE, DE
- BioNTech RNA Pharmaceuticals GmbH, DE
Prosecution history
- 12 Mar 2026 — NEW REPRESENTATIVE AT IB RECEIVED
- 10 Oct 2022 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 19 Sept 2022 — FINAL DISPOSITION NOTICE SENT TO IB
- 19 Sept 2022 — FINAL DISPOSITION PROCESSED
- 07 Sept 2022 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 07 Jun 2022 — EXPARTE APPEAL TERMINATED
- 07 Jun 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 07 Jun 2022 — REGISTERED-PRINCIPAL REGISTER
- 29 Apr 2022 — ELECTRONIC RECORD REVIEW COMPLETE
- 15 Apr 2022 — NEW REPRESENTATIVE AT IB RECEIVED
- 04 Apr 2022 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 01 Apr 2022 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 16 Mar 2022 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 16 Mar 2022 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 15 Feb 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED